Shopping Cart
- Remove All
- Your shopping cart is currently empty
Dilpacimab (ABT165), a potent dual-variable domain immunoglobulin, targets both the delta-like ligand 4 (DLL4) and VEGF pathways. It has potential applications in cancer research [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder |
Description | Dilpacimab (ABT165), a potent dual-variable domain immunoglobulin, targets both the delta-like ligand 4 (DLL4) and VEGF pathways. It has potential applications in cancer research [1]. |
Cas No. | 1791420-09-1 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.